ZimVie Jumps After Report on Buyout Talks With South Korea's Osstem
Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) P/E Still Appears To Be Reasonable
With a price-to-earnings (or "P/E") ratio of 23.7x Zimmer Biomet Holdings, Inc. (NYSE:ZBH) may be sending bearish signals at the moment, given that almost half of all companies in the United States
Truist Financial Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Announces Target Price $117
Truist Financial analyst Richard Newitter maintains $Zimmer Biomet Holdings(ZBH.US)$ with a hold rating, and sets the target price at $117.According to TipRanks data, the analyst has a success rate
Zimmer Biomet Holdings Is Maintained at Hold by Truist Securities
Zimmer Biomet Holdings Is Maintained at Hold by Truist
Morgan Stanley Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $120
Morgan Stanley analyst Drew Ranieri maintains $Zimmer Biomet Holdings(ZBH.US)$ with a hold rating, and maintains the target price at $120.According to TipRanks data, the analyst has a success rate
Express News | Zimmer Biomet Holdings Inc : Truist Securities Cuts Target Price to $117 From $130
Osteopore Taps Zimmer Biomet as Exclusive Distributor in EMEA, APAC; Shares Jump 30%
Osteopore (ASX:OSX) signed an exclusive distribution agreement with the Singapore-based subsidiary of New York-listed medical technology company Zimmer Biomet.Under the deal, Zimmer Biomet will
Zimmer Biomet Holdings Is Maintained at Equal-Weight by Morgan Stanley
Zimmer Biomet Holdings Is Maintained at Equal-Weight by Morgan
Unusual Options Activity: GPS, VLO and Others Attract Market Bets, GPS V/OI Ratio Reaches 37.9
EST Jul 15th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Express News | Zimmer Biomet Holdings Inc : Morgan Stanley Cuts Target Price to $120.00 From $130.00
Morgan Stanley Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Cuts Target Price to $120
Morgan Stanley analyst Drew Ranieri maintains $Zimmer Biomet Holdings(ZBH.US)$ with a hold rating, and adjusts the target price from $130 to $120.According to TipRanks data, the analyst has a
Morgan Stanley Cuts Price Target on Zimmer Biomet Holdings to $120 From $130, Keeps Equalweight Rating
Zimmer Biomet Holdings (ZBH) has an average investment rating of hold among analysts polled by Capital IQ, with price targets ranging from $112 to $175.Price: 108.75, Change: +0.06, Percent Change: +0
The Past Three Years for Zimmer Biomet Holdings (NYSE:ZBH) Investors Has Not Been Profitable
Citigroup Adjusts Price Target on Zimmer Biomet to $134 From $120
Zimmer Biomet Holdings (ZBH) has an average rating of hold and price targets ranging from $112 to $175, according to analysts by Capital IQ.
Express News | Citigroup Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $120
Goldman Sachs Adjusts Price Target on Zimmer Biomet Holdings to $118 From $129
Zimmer Biomet Holdings (ZBH) has an average hold rating and a price target range of $112 to $175, according to analysts polled by Capital IQ.
Citi Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Cuts Target Price to $120
Citi analyst Joanne Wuensch maintains $Zimmer Biomet Holdings(ZBH.US)$ with a hold rating, and adjusts the target price from $134 to $120.According to TipRanks data, the analyst has a success rate
Express News | Zimmer Biomet Holdings Inc : Citigroup Cuts Target Price to $120 From $134
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will be webcast on Wednesday, August 7,...
What Is Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Doing?
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) saw significant share price movement during recent months on the NYSE, rising to highs of US$133 and falling to the lows of US$106. Some share price movements c